Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis

Clinical trial NCT00331500 · COMPLETED

Trial details

NCT number: NCT00331500
Sponsor: Alcon Research
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Allergic Conjunctivitis

Start date: 2006-04-18
Primary completion: 2006-07-27
Enrollment: 287

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.